ICON offers the knowledge, software, systems and global footprint to make global adaptive trials a reality

Use of adaptive design has rapidly risen as sponsors capitalise on its ability to increase portfolio valuation by protecting good drugs from failure and improved decision-making at critical junctures in the development process.

ICON offers design, simulation and execution of adaptive clinical trials. We have:

  • More than fifteen years of experience in successfully planning and managing adaptive clinical trials
  • Experts with direct involvement in regulatory agency adoption of adaptive design trials and subsequent agency guidance
  • Operational teams and technologies to apply the power of adaptive techniques to drug and medical device trials

ICON is the only CRO to offer a validated design, simulation and analysis software platform for adaptive clinical trials. This platform, ADDPLAN, is used by regulatory agencies around the world: FDA (US), EMA (Europe) and PMDA (Japan).

File Thumbnail

Brochure: ADDPLAN® - ICON's Adaptive Trial Design Software

Read our brochure to learn about our expertise and experience in data management

  • 20%

    of Clinical trials in 2013 used an adaptive design

  • 30-60%

    Potential cost savings

  • 250

    Adaptive clinical trials for over 30 sponsors globally
File Thumbnail

Factsheet: Adaptive Design Capabilities

Download our factsheet to explore ICON's adaptive design capabilities

Additionally, you have access to the ICON Adaptive Trial Innovation Centre, a group of world leading experts in adaptive design and execution, providing leadership in these key areas:

  • Design, simulation and execution of adaptive trials across all phases of development
  • Development of innovative trial methodologies
  • Customized training in adaptive trial statistical methodology
  • Advice and guidance on the logistical and operational requirements for successful adaptive trial execution